Viloxazine hydrochloride, sold under the brand name Qelbree and formerly as Vivalan among others, is a morpholine derivative. It is a noradrenergic drug prescribed to treat attention deficit hyperactivity disorder (ADHD) in children and adults. Viloxazine is a non-stimulant medication; it has no known misuse liability and is not a controlled substance.
In Europe, it was sold as an antidepressant from 1974 until 2002, when it was discontinued for commercial reasons. It was repurposed for the treatment of ADHD and reintroduced in April 2021 in the United States.
|Name of Product||Viloxazine hydrochloride|
|Synonyms||Viloxazine HCl; Emovit; Vicilan; Vivalan; Viloxacina clorhidrato; Cloridrato de Viloxazina; Chlorhydrate de viloxazine|
|Molecular Weight||273.75 g/mol|
|2||Appearance (Colour)||White to beige|
|3||Solubility||DMSO: 2 mg/mL, clear|
|4||Melting Point||186-188 °C|
|5||Long storage temp.||2-8°C, dark|
Side effects observed in children (aged 6-17 years) are as follows:
Side effects observed in adults are as follows:
Q. Is Viloxazine FDA approved ?
In april 2021, Qelbree (viloxazine) has been licenced by the FDA to treat children and adults with attention-deficit hyperactivity disorder (ADHD).
Q. Where to purchase Viloxazine hydrochloride ?
Macsen Labs is a GMP and ISO certified manufacturer and supplier of high-quality Viloxazine hydrochloride.